SPIA
IMNP

Steward Partners Investment Advisory’s Immune Pharmaceuticals Inc. IMNP Stock Holding History

Steward Partners Investment Advisory’s Portfolio IMNP Stock Details IMNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-250
Closed – – 2799
2018
Q2 		$0 Hold
250
– – ﹤0.01% 2619
2018
Q1 		$0 Hold
250
– – ﹤0.01% 2404
2017
Q4 		$0 Hold
250
– – ﹤0.01% 2009
2017
Q3 		$0 Hold
250
– – ﹤0.01% 1823
2017
Q2 		$0 Hold
250
– – ﹤0.01% 1756
2017
Q1 		$0 Buy
+250
New +$902 ﹤0.01% 1612

Other funds holding IMNP

IP
Intellectus Partners San Francisco, California $490M AUM 35.11% 1-Year Est. Return

Steward Partners Investment Advisory's IMNP Position: Q3 2018 in Review

Steward Partners Investment Advisory sold out of Immune Pharmaceuticals Inc. (IMNP) in Q3 2018, closing a stake of 250 shares.

Steward Partners Investment Advisory first reported a position in IMNP in Q1 2017 and held it in 6 quarters. The position peaked at $0 in Q2 2018. 1 fund tracked by Wall St. Rank holds IMNP as of Q3 2018.

  • Steward Partners Investment Advisory reported no remaining Immune Pharmaceuticals Inc. position as of Q3 2018 after selling out during the quarter.
  • Steward Partners Investment Advisory sold 250 Immune Pharmaceuticals Inc. shares in Q3 2018.
  • Steward Partners Investment Advisory first reported a position in Immune Pharmaceuticals Inc. in Q1 2017 and held it in 6 quarters.
  • Steward Partners Investment Advisory's Immune Pharmaceuticals Inc. position peaked at $0 in Q2 2018.
  • 1 fund tracked by Wall St. Rank held Immune Pharmaceuticals Inc. as of Q3 2018.

Based on Steward Partners Investment Advisory's 13F filing for Q3 2018, filed 23 Oct 2018.